Literature DB >> 6702686

Conduction system abnormalities in symptomatic mitral valve prolapse: an electrophysiologic analysis of 60 patients.

J A Ware, S A Magro, J C Luck, D E Mann, A P Nielsen, K M Rosen, C R Wyndham.   

Abstract

This study examined the site of atrioventricular (AV) block in mitral valve prolapse (MVP). Sixty symptomatic patients with MVP underwent electrophysiologic study; 49 had documented arrhythmias and 28 had syncope. Eight patients had spontaneous second- or third-degree AV block and 10 had chronic bundle branch block. Electrophysiologic study revealed abnormal sinus node function in 8 patients, prolonged HV interval in 10, intra-Hisian delay in 9, and functional bundle branch block in 15. Dual AV nodal pathways were demonstrated in 24 patients. Comparison with 101 similarly symptomatic patients without MVP revealed a greater prevalence of dual AV nodal pathways in the MVP patients. Infranodal conduction abnormalities and dual AV nodal pathways are frequently revealed by electrophysiologic testing in symptomatic patients with MVP.

Entities:  

Mesh:

Year:  1984        PMID: 6702686     DOI: 10.1016/0002-9149(84)90640-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

Review 1.  Mitral valve prolapse associated with other disorders. Casual coincidence, common link, or fundamental genetic disturbance?

Authors:  A D Malcolm
Journal:  Br Heart J       Date:  1985-04

2.  A relationship between mitral valve prolapse and subtypes of supraventricular tachycardia.

Authors:  Alim Erdem; Osman Can Yontar; Serkan Öztürk; Suzi Selim Ayhan; Mehmet Fatih Özlü; Fatma Hizal Erdem; Mehmet Yazici
Journal:  J Interv Card Electrophysiol       Date:  2012-08-14       Impact factor: 1.900

3.  Mitral valve prolapse and conduction disturbances: the forgotten association.

Authors:  A D'aloia; E Vizzardi; E Antonioli; E Chiari; A Curnis; L Dei Cas
Journal:  Cardiovasc J Afr       Date:  2010 Nov-Dec       Impact factor: 1.167

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.